Important pharmacy news and late-breaking industry information updated daily.
HHS announced Wednesday that it is working with AstraZeneca to make available at least 300 million doses of an investigational coronavirus vaccine, aiming to deliver the first doses in October.
Health experts can agree that one of the silver linings of the COVID-19 pandemic is the way it has propelled telehealth forward. Like many other health professionals, some pharmacists have had to make a quick transition to telehealth.
Johnson & Johnson reports it will stop selling baby powder made with talcum in the United States and Canada. The move comes as consumer demand for the product declined amid safety concerns and as Johnson & Johnson faced a wave of lawsuits over the matter.
As the COVID-19 pandemic rages on, some hospitals are experiencing shortages of sedatives and paralytics used to keep intubated patients comfortably sedated. What can pharmacists do to conserve the supply of these key medications?
Preliminary results from the first human study of Moderna Inc.'s experimental coronavirus vaccine show the vaccine induced an immune response in some of the healthy volunteers who were vaccinated. In addition, the vaccine appears to be generally safe and well-tolerated, Moderna said.
Since the drug sorafenib was approved in 2007, no new first-line therapy has been shown to improve survival in patients with advanced liver cancer. But that could be changing.
Everlywell is the second company to be granted FDA's emergency clearance for an at-home coronavirus testing kit. FDA says the company "leveraged" data from studies supported by the Bill and Melinda Gates Foundation and UnitedHealth Group to show that the specimens would stay stable during shipping.
Pharmacists who compound veterinary medications have another month to respond to revised draft guidance on the compounding of animal drugs from bulk drug substances (BDS). The revised draft of Guidance for Industry (GFI) #256, Compounding Animal Drugs from Bulk Drug Substances, if finalized, will describe FDA’s current thinking about the practice and identify circumstances under which the agency does not intend to take regulatory action against the compounding of drugs from BDS when no other medically appropriate treatment options exist.
Digital pharmacy models such as Capsule and Amazon's PillPack have entered the marketplace to offer patients a pharmacy experience built on convenience. These models deliver medications directly to a patient’s door with a click of a button. Some fear that digital pharmacies may jeopardize the future of traditional brick-and-mortar pharmacies, but specialized services offered at the corner store simply cannot be replaced.
FDA is warning that preliminary data suggest that the Abbott ID NOW point-of-care test for diagnosing COVID-19 may return false negative results.